10 completed, 2 unknown, 1 active not recruiting. 13 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Completed 10, Unknown 2, Active not recruiting 1 |
Follow Japanese Encephalitis: new trials by email Literature Review of Japanese Encephalitis trials Research Report on Japanese Encephalitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas Liaoning Chengda Inactivated Japanese Encephalitis Vaccine - Japanese Encephalitis | Phase 4 | Active not recruiting | Liaoning Chengda Biotechnology CO., LTD | 250 | 2024-11-14 | 2024-12-13 |
| Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR) Vero cell-drived inactive Japanese encephalitis vaccine, Measles-Mumps-Rubella Vaccine - Japanese Encephalitis, Measles | Phase 4 | Completed | Liaoning Chengda Biotechnology CO., LTD | 408 | 2024-03-02 | 2025-08-28 |
| Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province Japanese Encephalitis Vaccine (Vero Cell), Inactivated;, No prospective interventions - Japanese Encephalitis, Vaccine Preventable Disease | Phase 4 | Unknown | Zhejiang Provincial Center for Disease Control and Prevention | 712 | 2021-03-01 | 2022-11-15 |
| Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines Measles-Rubella combined vaccine(MR), Japanese Encephalitis alive vaccine(JE) - Measles, Rubella | Phase 4 | Completed | Centers for Disease Control and Prevention, China | 1043 | 2015-08-01 | 2016-08-01 |
| Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj Japanese encephalitis vaccine - Japanese Encephalitis | Phase 4 | Completed | Boryung Pharmaceutical Co., Ltd | 94 | 2015-08-01 | 2017-02-06 |
| Post-licensure Safety Study of IMOJEV® in Thailand IMOJEV®: Live attenuated Japanese encephalitis chimeric virus vaccine - Japanese Encephalitis | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 10000 | 2013-11-01 | 2016-05-04 |
| Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Japanese encephalitis chimeric vaccine (JECV) - Japanese Encephalitis | Phase 4 | Unknown | Khon Kaen University | 88 | 2013-10-01 | 2013-10-08 |
| Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine Live Attenuated Varicella Vaccine + Live Attenuated JE Vaccine, Live Attenuated Varicella Vaccine, live attenuated JE vaccine - Japanese Encephalitis, Chickenpox | Phase 4 | Completed | Changchun Keygen Biological Products Co., Ltd. | 497 | 2013-03-01 | 2014-02-24 |
| A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2 Live attenuated Japanese encephalitis vaccine SA14-14-2 - Japanese Encephalitis, Japanese Encephalitis Vaccine | Phase 4 | Completed | Indian Institute of Science | 17 | 2012-05-01 | 2019-04-26 |
| Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine Vaccine produced in existing facility, Vaccine produced in new facility - Japanese Encephalitis | Phase 4 | Completed | PATH | 818 | 2012-05-01 | 2018-12-05 |
| This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population IXIARO® - Japanese Encephalitis | Phase 4 | Completed | Valneva Austria GmbH | 200 | 2010-06-01 | 2012-03-23 |
| Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine Live, Attenuated Japanese Encephalitis SA 14-14-2 Vaccine (LJEV) - Japanese Encephalitis | Phase 4 | Completed | PATH | 305 | 2007-07-09 | 2020-03-31 |
| Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age Live, Attenuated Japanese Encephalitis SA 14-14-2 Vaccine, Live, attenuated measles vaccine - Japanese Encephalitis | Phase 4 | Completed | PATH | 278 | 2007-07-07 | 2019-02-08 |
Encephalitis, Japanese (13) · Measles (2) · Rubella (2) · Chickenpox (1) · Mumps (1) · Vaccine-Preventable Diseases (1)
Arbovirus Infections (13) · Brain Diseases (13) · Central Nervous System Diseases (13) · Central Nervous System Infections (13) · Central Nervous System Viral Diseases (13) · Encephalitis (13) · Encephalitis, Arbovirus (13) · Encephalitis, Viral (13) · Flaviviridae Infections (13) · Flavivirus Infections (13) · Infections (13) · Infectious Encephalitis (13) · Mosquito-Borne Diseases (13) · Nervous System Diseases (13) · Neuroinflammatory Diseases (13)
Japanese Encephalitis Vaccines (2) · Measles-Mumps-Rubella Vaccine (1)
PATH (3) · Liaoning Chengda Biotechnology CO., LTD (2) · Boryung Pharmaceutical Co., Ltd (1) · Centers for Disease Control and Prevention, China (1) · Changchun Keygen Biological Products Co., Ltd. (1) · Indian Institute of Science (1) · Khon Kaen University (1) · Sanofi Pasteur, a Sanofi Company (1) · Valneva Austria GmbH (1) · Zhejiang Provincial Center for Disease Control and Prevention (1)
China (5) · Sri Lanka (2) · Thailand (2) · Austria (1) · Bangladesh (1) · Germany (1) · India (1) · South Korea (1)
Nihal Abeysinghe, MD, MSc (2) · Dr V Ravi, MBBS MD (1) · HJ Jung, MD (1) · Huanyu Wang (1) · Huaqing Wang, MD, PhD (1) · K Zaman, MD (1) · Pope Kosalaraksa, M.D. (1) · Prof S Vijaya, PhD (1) · Xing Fang (1) · Zheng Huizhen, Master (1) · Zhijie AN, MD, MPH (1) · Zijian Feng, MD, MPH (1)